Ausgewählte Studien

Folgen

From the Cochrane Library: Antistreptococcal interventions for guttate and chronic plaque psoriasis
From the Cochrane Library: Antistreptococcal interventions for guttate and chronic plaque psoriasis

Automat · 22. Dezember 20222 Jr.

Key words To the Editor: Psoriasis is an inflammatory dermatologic disease that affects 2% to 3% of individuals worldwide, and guttate psoriasis is a …Den ganzen Artikel lesen
Automat

22. Dezember 20222 Jr.
- 249 Aufrufe
Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms
Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms

Automat · 22. Dezember 20222 Jr.

The contribution of nutrient availability to control epidermal cell proliferation, inflammation, and hyperproliferative diseases remains unknown. …Den ganzen Artikel lesen
Automat

22. Dezember 20222 Jr.
- 212 Aufrufe
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30<sup>th</sup> EADV Congress 2021
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30<sup>th</sup> EADV Congress 2021

Automat · 22. Dezember 20222 Jr.

J Eur Acad Dermatol Venereol. 2023 Jan;37 Suppl 1:3-8. doi: 10.1111/jdv.18761. NO ABSTRACT PMID:36546464 | DOI:10.1111/jdv.18761 Den ganzen Artikel lesen
Automat

22. Dezember 20222 Jr.
- 250 Aufrufe
The Relationship of Depression and Systemic Inflammation in Psoriasis; Findings from the UK Biobank
The Relationship of Depression and Systemic Inflammation in Psoriasis; Findings from the UK Biobank

Automat · 22. Dezember 20222 Jr.

Psoriasis is regarded as a systemic inflammatory disease, however the significance of inflammatory burden for psychiatric comorbidity is not clear …Den ganzen Artikel lesen
Automat

22. Dezember 20222 Jr.
- 174 Aufrufe
Risankizumab in patients with Crohn's disease
Risankizumab in patients with Crohn's disease

Automat · 14. Dezember 20222 Jr.

Inn Med (Heidelb). 2023 Jan;64(1):102-106. doi: 10.1007/s00108-022-01414-9. Epub 2022 Dec 14. NO ABSTRACT PMID:36515721 | DOI:10.1007/s00108-022-01414-9 Den ganzen Artikel lesen
Automat

14. Dezember 20222 Jr.
- 146 Aufrufe
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative - PubMed
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative - PubMed

Automat · 10. Dezember 20222 Jr.

Introduction: Despite advances in treatment options and the management of patients with psoriasis, considerable unmet needs remain. Our objective was …Den ganzen Artikel lesen
Automat

10. Dezember 20222 Jr.
- 207 Aufrufe
Oral orismilast: Efficacy and safety in moderate‐to‐severe psoriasis and development of modified release tablets
Oral orismilast: Efficacy and safety in moderate‐to‐severe psoriasis and development of modified release tablets

Automat · 9. Dezember 20222 Jr.

ORIGINAL ARTICLE Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets R. B. …Den ganzen Artikel lesen
Automat

9. Dezember 20222 Jr.
- 269 Aufrufe
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative

Automat · 9. Dezember 20222 Jr.

Dermatol Ther (Heidelb). 2022 Dec 9:1-24. doi: 10.1007/s13555-022-00846-3. Online ahead of print. NO ABSTRACT PMID:36484915 | PMC:PMC9734585 | DOI:10.1007/s13555-022-00846-3 Den ganzen Artikel lesen
Automat

9. Dezember 20222 Jr.
- 187 Aufrufe
Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitis
Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitis

Automat · 9. Dezember 20222 Jr.

Commun Biol. 2022 Dec 8;5(1):1348. doi: 10.1038/s42003-022-04279-8. NO ABSTRACT PMID:36482174 | PMC:PMC9731970 | DOI:10.1038/s42003-022-04279-8 Den ganzen Artikel lesen
Automat

9. Dezember 20222 Jr.
- 203 Aufrufe
The effectiveness and safety of mirikizumab for treatment of psoriasis
The effectiveness and safety of mirikizumab for treatment of psoriasis

Automat · 5. Dezember 20222 Jr.

Plaque psoriasis is a common skin disease that affects about 125 million people worldwide. The condition is caused by an overactive immune system …Den ganzen Artikel lesen
Automat

5. Dezember 20222 Jr.
- 218 Aufrufe
Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization
Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization

Automat · 5. Dezember 20222 Jr.

Br J Dermatol. 2022 Dec;187(6):1007-1008. doi: 10.1111/bjd.21827. Epub 2022 Sep 6. NO ABSTRACT PMID:36464934 | DOI:10.1111/bjd.21827 Den ganzen Artikel lesen
Automat

5. Dezember 20222 Jr.
- 183 Aufrufe
Cochrane Skin Group’s Global Social Media Reach: Content Analysis of Facebook, Instagram, and Twitter Posts
Cochrane Skin Group’s Global Social Media Reach: Content Analysis of Facebook, Instagram, and Twitter Posts

Automat · 2. Dezember 20222 Jr.

Short Paper Background: Researchers in all medical specialties increasingly use social media to educate the public, share new publications with peers, …Den ganzen Artikel lesen
Automat

2. Dezember 20222 Jr.
- 268 Aufrufe
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)

Automat · 1. Dezember 20222 Jr.

Dermatol Ther (Heidelb). 2022 Dec 1. doi: 10.1007/s13555-022-00863-2. Online ahead of print. NO ABSTRACT PMID:36456890 | DOI:10.1007/s13555-022-00863-2 Den ganzen Artikel lesen
Automat

1. Dezember 20222 Jr.
- 198 Aufrufe
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey - PubMed
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey - PubMed

Automat · 20. November 20222 Jr.

Full text linksCite Display options Display options Erratum in Correction to: Evolution of Patient Perceptions of Psoriatic Disease: Results from the …Den ganzen Artikel lesen
Automat

20. November 20222 Jr.
- 179 Aufrufe
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial - PubMed
One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial - PubMed

Automat · 20. November 20222 Jr.

Full text linksCite Display options Display options Background: Tapinarof cream 1% once daily, an aryl hydrocarbon receptor-modulating agent, was …Den ganzen Artikel lesen
Automat

20. November 20222 Jr.
- 174 Aufrufe
Should we customize the treatment with interleukin‐17A inhibitors for moderate‐to‐severe psoriasis in the real‐world setting?
Should we customize the treatment with interleukin‐17A inhibitors for moderate‐to‐severe psoriasis in the real‐world setting?

Automat · 20. November 20222 Jr.

Kun Hu, Kun Hu Department of dermatology, Xiangya Hospital of Central South University, Changsha, China Search for more papers by this author Mi Zhang, Mi …Den ganzen Artikel lesen
Automat

20. November 20222 Jr.
- 248 Aufrufe
Response to the article by Naik et al. entitled “Anakinra for Refractory Pustular Psoriasis: A Phase II, Open Label, Dose-Escalation Trial”
Response to the article by Naik et al. entitled “Anakinra for Refractory Pustular Psoriasis: A Phase II, Open Label, Dose-Escalation Trial”

Automat · 20. November 20222 Jr.

Den ganzen Artikel lesen
Automat

20. November 20222 Jr.
- 271 Aufrufe
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial - PubMed
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial - PubMed

Automat · 20. November 20222 Jr.

Introduction/background: Manifestations of psoriasis in special areas are difficult to treat and are associated with a high disease burden and …Den ganzen Artikel lesen
Automat

20. November 20222 Jr.
- 174 Aufrufe
Der dermatologischen Glücksforschung system(at)isch auf der Spur
Der dermatologischen Glücksforschung system(at)isch auf der Spur

Automat · 18. November 20222 Jr.

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 20, Issue 11, Page 1415-1417, November 2022.Den ganzen Artikel lesen
Automat

18. November 20222 Jr.
- 270 Aufrufe
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model

Automat · 15. November 20222 Jr.

Commun Biol. 2022 Nov 15;5(1):1250. doi: 10.1038/s42003-022-04179-x. ABSTRACT T-cell-driven immune responses are responsible for several autoimmune disorders, such as psoriasis vulgaris and rheumatoid arthritis. Identification of metabolic signatures in inflamed tissues is needed to facilitate novel and individualised therapeutic developments. Here we show the temporal metabolic dynamics of T-cell-driven inflammation characterised by nuclear magnetic resonance spectroscopy-based metabolomics, hi
Automat

15. November 20222 Jr.
- 210 Aufrufe
Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?
Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?

Automat · 8. Oktober 20222 Jr.

LETTER TO THE EDITOR Can people take high-quality images using mobile dermatoscopes at home on easy-to-see and difficult-to-see body areas? Astrid J. …Den ganzen Artikel lesen
Automat

8. Oktober 20222 Jr.
- 311 Aufrufe
A 9-Year Teledermoscopy Service in New Zealand: Retrospective Service Review
A 9-Year Teledermoscopy Service in New Zealand: Retrospective Service Review

Automat · 8. Oktober 20222 Jr.

Original Paper Background: A teledermoscopy service was established in January 2010 wherein patients attended nurse-led clinics for the imaging of …Den ganzen Artikel lesen
Automat

8. Oktober 20222 Jr.
- 184 Aufrufe
Social media voices on the treatment of skin psoriasis with biologics - PubMed
Social media voices on the treatment of skin psoriasis with biologics - PubMed

Automat · 7. Oktober 20222 Jr.

Gorrepati PL, Smith GP. Gorrepati PL, et al. J Dermatolog Treat. 2022 Aug;33(5):2685-2686. doi: 10.1080/09546634.2022.2037497. Epub 2022 Feb 7. J …Den ganzen Artikel lesen
Automat

7. Oktober 20222 Jr.
- 151 Aufrufe
Psoriasis of the external auditory canal: prevalence, clinical features and impact on quality of life
Psoriasis of the external auditory canal: prevalence, clinical features and impact on quality of life

Automat · 7. Oktober 20222 Jr.

Cristina Galache, Cristina Galache Department of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain Group of Investigation on …Den ganzen Artikel lesen
Automat

7. Oktober 20222 Jr.
- 246 Aufrufe
Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy
Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy

Automat · 7. Oktober 20222 Jr.

Den ganzen Artikel lesen
Automat

7. Oktober 20222 Jr.
- 200 Aufrufe

Folgen

Anmelden

Ausgewählte Studien

519 Datensätze in dieser Kategorie

From the Cochrane Library: Antistreptococcal interventions for guttate and chronic plaque psoriasis

Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms

The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30<sup>th</sup> EADV Congress 2021

The Relationship of Depression and Systemic Inflammation in Psoriasis; Findings from the UK Biobank

Risankizumab in patients with Crohn's disease

Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative - PubMed

Oral orismilast: Efficacy and safety in moderate‐to‐severe psoriasis and development of modified release tablets

Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative

Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitis

The effectiveness and safety of mirikizumab for treatment of psoriasis

Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization

Cochrane Skin Group’s Global Social Media Reach: Content Analysis of Facebook, Instagram, and Twitter Posts

Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)

Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey - PubMed

One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial - PubMed

Should we customize the treatment with interleukin‐17A inhibitors for moderate‐to‐severe psoriasis in the real‐world setting?

Response to the article by Naik et al. entitled “Anakinra for Refractory Pustular Psoriasis: A Phase II, Open Label, Dose-Escalation Trial”

Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial - PubMed

Der dermatologischen Glücksforschung system(at)isch auf der Spur

Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model

Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?

A 9-Year Teledermoscopy Service in New Zealand: Retrospective Service Review

Social media voices on the treatment of skin psoriasis with biologics - PubMed

Psoriasis of the external auditory canal: prevalence, clinical features and impact on quality of life

Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy

Table of Contents

Account

Navigation

Suche